Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Whole Foods rehearing petition denied

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Court of Appeals for the District of Columbia Circuit rejects the supermarket chain's request for a rehearing en banc concerning its acquisition of Wild Oats Markets, following the court's July ruling in favor of the Federal Trade Commission, according to a Nov. 21 order. FTC claims the merger between Austin, Texas-based Whole Foods and Boulder, Colo.-based Wild Oats limits competition in the "premium, natural and organic supermarket" segment. "We look forward to presenting our evidence as to why this merger is unlawful" at the administrative trial before the commission, scheduled for Feb. 16, says David Wales, FTC's Bureau of Competition acting director. Wales adds the agency wants to maintain competition and reach "a meaningful remedy." FTC indicated interest in settling, though Whole Foods may seek certiorari before the Supreme Court, which has shown pro-merger sentiments (1"The Tan Sheet" Aug. 18, 2008, p. 6)

You may also be interested in...



FTC competition head departs

David Wales leaves in May after nine months as acting director of the Federal Trade Commission's Bureau of Competition, the agency says in an April 2 statement. Wales joined FTC in April 2006 as deputy director of the bureau and oversaw cases including the settlement of the Whole Foods and Wild Oats Markets merger, and Inverness Medical Innovations' alleged anticompetitive purchase of a pregnancy test technology (1"The Tan Sheet" Dec. 1, 2008, In Brief and 2"The Tan Sheet" Jan. 5, 2009, p. 14)

Whole Foods strikes back

The supermarket chain seeks an injunction in the U.S. District Court for the District of Columbia against the Federal Trade Commission for attempting to deprive the company of its due process rights, Whole Foods says Dec. 8. Whole Foods contends FTC prejudged the company's merger with Wild Oats Markets and, after an appeals court overturned a lower court's denial of an injunction the commission sought against the merger, scheduled an administrative trial for Feb. 16 that forces Whole Foods to "defend itself in 29 separate geographic jurisdictions in a merger that was not anti-competitive," says Lanny Davis, attorney for the Austin, Texas-based chain. Co-founder and CEO John Mackey says consumers already benefit from the September 2007 merger with lower prices and higher quality. Whole Foods argues an unbiased federal judge should hear the case rather than FTC commissioners. An appeals court recently rejected the company's request for a rehearing en banc (1"The Tan Sheet" Dec. 1, 2008, In Brief)

Whole Foods Merger Ruling Could “Embolden” Antitrust Activity – Attorney

An appeals court's questions about a merger in a key market for dietary supplement manufacturers - the Whole Foods/Wild Oats Markets deal - may impede similar deals across all U.S. industries, an antitrust law expert says

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel